Patent Information filled during CTC.
| Title | Patent Number(s) | Assignee | Inventor(s) |
| Animal cloning method, involves transferring somatic cell and/or embryonic cell during induced and/or natural programmed cell death i.e. apoptosis | BR200801863-A2 | University of São Paulo; FAPESP | Bressan FF, Meirelles FV, Merighe GKF, et al. |
| Human blood coagulation Factor IX recombinant protein, use of a Factor IX recombinant protein, use of a composition, method of obtaining human blood coagulation Factor IX recombinant protein and use of the Factor IX recombinant protein | BR 2009/000240 | Fundação Hemocentro de Ribeirão Preto and University of São Paulo | Covas DT and Fontes AM |
| Factor VIII human blood coagulation recombinant protein | EP 2 180 009 | Fundação Hemocentro de Ribeirão Preto and University of São Paulo | Covas DT and Fontes AM |
| Large-scale and stable production of human FVIII in the human cell line Sk-Hep-1 | INPI 018110002212 | Fundação Hemocentro de Ribeirão Preto and University of São Paulo | Covas DT, Picanço-Castro V,
CarbolanteEMSR, Swiech K |
| Large-scale and stable production of human FVIII in the human cell line Sk-Hep-1 | US 8969041 B2 | Covas DT, Carbolante EMSR, Picanço-Castro V | |
| Stable and a large-scale production of human FVIII in human cell line Sk-Hep-1 | P.I. 11053178 | Fundação Hemocentro de Ribeirão Preto and University of São Paulo | Covas DT, Carbolante EMSR, Picanço-Castro V |
| Molecular diagnostic kit for HTLV-½ infection – set of oligonucleotides, method to detect and discriminate HTLV-1/2 targets and kit for diagnosis and discrimination of HTLV-½ infection | BR112017 006905-9 | Fundação Hemocentro de Ribeirão Preto and University of São Paulo | Covas DT,
Rocha-Junior MC, Kashima,- S |
| Process of production of blood clotting Factor VII | BR 1020150123345 | Fundação Hemocentro de Ribeirão Preto and University of São Paulo | Covas DT, Freitas, M, Picanço-Castro, V, Swiech, K. |
| New CAR constructs that modulate IL-15 or IL-27 pathways. Nucleic acid sequence that encodes a natural killer chimeric antigen receptor (NK-CAR), polypeptide of the referred NK-CAR, vector that comprises the referred nucleic acid sequence, in vitro method for obtaining a NK cell, use of the referred sequence, polypeptide or vector, and pharmaceutical composition. | BR 10 2022 008333-9 | Fundação Hemocentro de Ribeirão Preto | Covas DT, Picanço-Castro V, Calado RT, Silvestre, RN |
| Human recombinant Factor IX variants with increased biological activity and use of them | BR 10 2019 007372-1 | Fundação Hemocentro de Ribeirão Preto and University of São Paulo | Covas DT, Picanço-Castro V, Bonfim AS, Carbolante EMSR, |